TAK-652, a novel CCR5 inhibitor, has favourable drug interactions with other antiretrovirals in vitro. [electronic resource]

By: Contributor(s): Producer: 20060223Description: 967-8 p. digitalISSN:
  • 1359-6535
Subject(s): In: Antiviral therapy vol. 10
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Letter

There are no comments on this title.

to post a comment.